e-learning
resources
London 2016
Sunday, 04.09.2016
Molecular pathways of smoking-induced diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The neurogenic inflammation markers in rat’s brain in experimental smoking
Vera Nevzorova (Vladivostok, Primorsky Krai, Russian Federation), Vera Nevzorova, Natalia Zakharchuk, Elena Gonchar
Source:
International Congress 2016 – Molecular pathways of smoking-induced diseases
Session:
Molecular pathways of smoking-induced diseases
Session type:
Oral Presentation
Number:
1483
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Vera Nevzorova (Vladivostok, Primorsky Krai, Russian Federation), Vera Nevzorova, Natalia Zakharchuk, Elena Gonchar. The neurogenic inflammation markers in rat’s brain in experimental smoking. Eur Respir J 2016; 48: Suppl. 60, 1483
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Antioxidant effects of bisphosphonates in smoking- induced lung injury in rat model
Source: International Congress 2015 – New models for treating airway diseases
Year: 2015
A short-term model of COPD identifies a role for mast cell tryptase
Source: Annual Congress 2013 –Novel mechanisms in lung injury
Year: 2013
Characterisation of an experimental mouse model of exposure to nanoparticles. Relevance to human sarcoidosis
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015
The role of lL-17 in the OVA-LPS driven model of lung inflammation
Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Year: 2015
Therapeutic neutralization of the matrikine PGP suppresses the development of lung emphysema in cigarette smoke exposed mice
Source: International Congress 2016 – Mechanisms of disease
Year: 2016
Acute markers of neutrophilic lung infiltration in the non-human primate LPS model
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014
Antioxidant activity of pomegranate juice reduces lung injury secondary to secondary to acute and chronic cigarette smoke exposure in an animal model
Source: Annual Congress 2013 –The multiple faces of stress in lung injury
Year: 2013
High fructose intake increases alveolar enlargement and muscle inflammation in mice exposed to cigarette smoke
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
Implication of interleukin-10 in the development of COPD induced by cigarette smoke exposure in mice
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
Chronic intermittent hypoxia induces liver injury in mice with diet induced obesity via TLR4/MyD88/MAPK/NF-kB signaling pathways
Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea
Year: 2016
A novel non-human primate model of cigarette smoke-induced chronic obstructive pulmonary disease
Source: International Congress 2014 – Animal models: asthma, COPD and beyond
Year: 2014
Comparison of the effects of e-cigarette vapor vs cigarette smoke on lung function and inflammation in mice
Source: International Congress 2015 – Emerging data on (e-)cigarettes and their health hazards
Year: 2015
Adipose derived stem cells ameliorate airway inflammation in mouse models of asthma
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015
Nicotine impairs inflammation-induced airway relaxation in a in vitro murine model of asthma
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013
Developing a chronic murine model that better reflects the clinical features of the human asthma
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016
Abnormal vitamin D status negatively affects lung function and inflammation in smoking mice
Source: International Congress 2014 – Animal models: asthma, COPD and beyond
Year: 2014
Promotion of lung cancer progression by COPD-like chronic inflammation in a mouse model
Source: Annual Congress 2013 –Basic research on lung cancer
Year: 2013
Effects of chronic cigarette smoke exposure on lung inflammation in ovalbumin-sensitized mice
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014
Cigarette smoke-induced lung inflammation is skewed in estrogen receptor-alpha deficient mice
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept